noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

Business and Economy > Industry News > Pharmaceuticals and Biotechnology

related tags Pharmaceutical Companies Animal Pharmaceutical Companies Drug Retailers and Distributors

Results Pharmaceuticals and Biotechnology

FDA - Food and Drug Administration

Eridanous (Eridanous Shortbread Cookies with Chocolate Truffle Coating & Apricot Filling 11.6 oz (330 g) box/Lidl US) Recall reason: Additional product with undeclared wheat, soy, milk, and egg allergens due to foreign language packaging that did not contain English ingredients, nutrition facts, or allergen declarations.

-14h 58m
California Board of Pharmacy

August 2026 - News Roundup

-19h 13m
Swissmedic - Swiss Agency for Therapeutic Products

Changes to the guidance document RMP ICH E2E information submission HMP

-20h 52m
Swissmedic - Swiss Agency for Therapeutic Products

Updating of the information sheet Guidance for Industry on the electronic exchange of ICSRs in E2B(R3) format through B2B gateway

-21h 2m
Swissmedic - Swiss Agency for Therapeutic Products

Changes to the questions and answers and guidance document on mobile technologies

-21h 2m
NCPA - National Community Pharmacists Association

NCPA Announces Keynote Speakers for Annual Convention

yesterday
FDA - Food and Drug Administration

GreenWise (Organic IQF Frozen Blueberries and Whole Mixed Berries, 10 oz and 48 oz/Publix) Recall reason: Possible E. Coli Contamination

yesterday
FDA - Food and Drug Administration

Rooted in RARE (Aquafaba Powder 4oz (113g) and (12 oz (340g) flexible foil pouches/529 Commerce, LLC) Recall reason: Undeclared egg allergen

yesterday
MHRA - Medicines and Healthcare products Regulatory Agency

Thousands of patients to benefit from new daily pill for serious heart condition following co-ordinated MHRA and NICE decisions

-2d
FDA - Food and Drug Administration

July 29, 2026 - FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.

-2d